157 related articles for article (PubMed ID: 31566407)
1. The effect of Salvia miltiorrhiza in a mouse model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yang L; Huo JR; Zhu HY; Chen Z; Wang XY
Rev Esp Enferm Dig; 2019 Nov; 111(11):823-827. PubMed ID: 31566407
[TBL] [Abstract][Full Text] [Related]
2. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yao J; Wu J; Jia S; Shao J; Zhang X; Xu Z; Zhang H; Li H; Yao X
J Clin Lab Anal; 2022 Dec; 36(12):e24793. PubMed ID: 36447383
[TBL] [Abstract][Full Text] [Related]
3. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.
Ou P; Liu X; Tang Z; Hou Z; Liu L; Liu J; Zhou S; Fang Z; Sun K; Chen Y; Chen X; Li Y; Chen J
Curr Pharm Des; 2019; 25(35):3762-3768. PubMed ID: 31589115
[TBL] [Abstract][Full Text] [Related]
4. Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.
Zhang H; Jia S; Jin L; Mb JY; Shen Z; Wu J; Yao X; Chen D; Zhang C; Yu S; Zhu N; Jin L; Yao X
Acta Cir Bras; 2022; 36(11):e361104. PubMed ID: 35195181
[TBL] [Abstract][Full Text] [Related]
5. Effect of prednisone on transforming growth factor-β1, connective tissue growth factor, nuclear factor-κBp65 and tumor necrosis factor-α expression in a murine model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Zhu H; Chu Y; Huo J; Chen Z; Yang L
Hepatol Res; 2011 Aug; 41(8):795-803. PubMed ID: 21699635
[TBL] [Abstract][Full Text] [Related]
6. Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yu XZ; Ji T; Bai XL; Liang L; Wang LY; Chen W; Liang TB
J Zhejiang Univ Sci B; 2013 Jan; 14(1):68-75. PubMed ID: 23303633
[TBL] [Abstract][Full Text] [Related]
7. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.
Zhang F; Zhou Y; Yang X; Xiong AZ; Wang ZT; Yang L
Acta Pharmacol Sin; 2019 Jun; 40(6):781-789. PubMed ID: 30367152
[TBL] [Abstract][Full Text] [Related]
8. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
[TBL] [Abstract][Full Text] [Related]
9. Hepatic veno-occlusive disease related to Gynura segetum: A case report.
Sun Z; Kang J; Zhang Y
Medicine (Baltimore); 2018 Apr; 97(17):e0552. PubMed ID: 29703039
[TBL] [Abstract][Full Text] [Related]
10. Hepatic sinusoidal obstruction syndrome caused by the ingestion of
Cen P; Ding J; Jin J
J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Salvia miltiorrhiza and Carthamus tinctorius extract against lipopolysaccharide-induced liver injury.
Gao LN; Yan K; Cui YL; Fan GW; Wang YF
World J Gastroenterol; 2015 Aug; 21(30):9079-92. PubMed ID: 26290634
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study.
Wang Y; Qiao D; Li Y; Xu F
BMC Gastroenterol; 2018 Oct; 18(1):156. PubMed ID: 30367628
[TBL] [Abstract][Full Text] [Related]
13. Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum.
Chen Z; Huo JR; Yang L; Zhu HY
J Gastroenterol Hepatol; 2011 Jun; 26(6):1016-21. PubMed ID: 21251065
[TBL] [Abstract][Full Text] [Related]
14. The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression.
Chang CC; Chu CF; Wang CN; Wu HT; Bi KW; Pang JH; Huang ST
Phytomedicine; 2014 Feb; 21(3):207-16. PubMed ID: 24157079
[TBL] [Abstract][Full Text] [Related]
15. Hepatic sinusoidal obstruction syndrome after oral intake of Gynura segetum.
Zhang C; Wu Z; Wang F; Shi L
Asian J Surg; 2021 Jul; 44(7):991-993. PubMed ID: 33926799
[No Abstract] [Full Text] [Related]
16. [Clinical condition evaluation of hepatic veno-occlusive disease induced by gynura segetum].
Wu XJ; Yu MY; Yan YW
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):635-6. PubMed ID: 24163873
[No Abstract] [Full Text] [Related]
17. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome.
Tan Y; Zhou X
Medicine (Baltimore); 2024 Feb; 103(6):e35914. PubMed ID: 38335400
[TBL] [Abstract][Full Text] [Related]
18. [Hematologic toxicity of Gynura segetum and effects on vascular endothelium in a rat model of hepatic veno-occlusive disease].
Fang J; Zhang G; Teng X; Zhang Z; Pan J; Shou Q; Chen M
Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):59-63. PubMed ID: 25751389
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.
Kan X; Ye J; Rong X; Lu Z; Li X; Wang Y; Yang L; Xu K; Song Y; Hou X
Sci Rep; 2016 Nov; 6():37998. PubMed ID: 27897243
[TBL] [Abstract][Full Text] [Related]
20. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
